베타
임상 레이더 AI

위치 Research Site에 맞는 임상 시험을 보여주고 있습니다.

건강 상태와 치료법을 이해하고 근처 임상 시험을 찾는 데 도움을 드릴 수 있어요.
저희 검색 도구는 영어만 지원합니다. 다른 언어로 검색하고 싶으시면 상단의 임상 레이더 AI를 사용하거나 아래 질환명 및 위치 필터를 선택하세요.
21개 결과
 
상태 (기본)
대상자모집전, 모집중, 진행중, 모집종료
×
 
위치
Research Site
×
 
개입/치료
GLP-1
×
 
임상시험 제목
상태
A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs (EXCEED) NCT05663515
모집중
A Study to Evaluate the Efficacy and Safety of Once-Weekly MET097 in Adults With Obesity or Overweight and T2DM (VESPER-2) NCT06897202
진행중, 모집종료
A Phase 2b Study to Examine the Safety and Efficacy of Once-Weekly MET097 in Adults With Obesity or Overweight (VESPER-1) NCT06712836
진행중, 모집종료
Efficacy and Safety of GZR18 Every 2 Weeks Versus Tirzepatide and Placebo in Obese or Overweight Participants NCT06737042
대상자모집전
A Study to Evaluate DD01 in Overweight/Obese Subjects With MASLD/MASH NCT06410924
진행중, 모집종료
Efficacy, Safety and Tolerability of AZD6234 in Participants Living With Overweight or Obesity With Type 2 Diabetes Who Are on a Stable Dose of GLP-1 Receptor Agonist (ARAY) NCT06851858
진행중, 모집종료
A Phase 2b Study to Evaluate the Efficacy and Safety of Once-Monthly MET097 in Adults With Obesity or Overweight (VESPER-3) NCT06973720
진행중, 모집종료
Aleniglipron Phase 2 Body Composition Study NCT07169942
진행중, 모집종료
A Study of MET233 in Combination With MET097 in Individuals With Obesity or Overweight With or Without Diabetes NCT06924320
모집중
A Dose-Range Study of Aleniglipron (GSBR-1290) in Participants Living With Obesity or Overweight With at Least One Weight-related Comorbidity (ACCESS II) NCT06703021
진행중, 모집종료
A Phase 2b, Dose-range Finding Study of the Efficacy and Safety of Multiple Doses of Aleniglipron (GSBR-1290) in Participants Living With Obesity or Overweight With at Least One Weight-related Comorbidity (ACCESS) NCT06693843
진행중, 모집종료
A Study of Tirzepatide (LY3298176) Plus Mibavademab Compared With Tirzepatide Alone in Adult Participants With Obesity NCT06373146
진행중, 모집종료
A Study to Investigate the Pharmacokinetics of Different Formulations and Safety of AZD5004 in Healthy Participants Aged 18 to 55 Years NCT07455825
모집중
Study of ARO-INHBE in Adults With Obesity With and Without Diabetes Mellitus NCT06700538
모집중
Phase 1/1b Study of TLC-6740 in Healthy Subjects and Subjects With Obesity, With or Without Diabetes NCT05822544
모집중
Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Moderate-to-Severe Plaque Psoriasis and Obesity or Overweight (TOGETHER-PsO) NCT06588283
진행중, 모집종료
Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Psoriatic Arthritis and Obesity or Overweight (TOGETHER-PsA) NCT06588296
진행중, 모집종료
A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes (SURPASS-EARLY) NCT05433584
진행중, 모집종료
A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity (SURMOUNT-MMO) NCT05556512
진행중, 모집종료
A Study of Tirzepatide (LY3298176) Compared With Placebo in Adults With Type 1 Diabetes and Obesity or Overweight (SURPASS-T1D-1) NCT06914895
진행중, 모집종료
A Long-Term Study of Tirzepatide (LY3298176) in Adults With Type 1 Diabetes and Obesity or Overweight (SURPASS-T1D-2) NCT06962280
진행중, 모집종료